ANGO
AngioDynamicsANasdaq / Health Care Equipment & Services
Last Price
At close
2026-07-17
Current thesis
Record Q4 results, seventh consecutive quarter of double-digit Med Tech growth, FY2027 guidance, NanoKnife reimbursement progress, and a debt-free balance sheet support a constructive medium-term case [#SEC-8K-2026-07-14].
Posture
Constructive
Lead driver
Sentiment
What changed
Sentiment remains the lead driver in the composite, 7D delta -16.4.
What can break
Clinical, regulatory, and reimbursement milestones may not convert into adoption or cash flow on schedule.
Momentum
76
Value
42
Sentiment
73
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $18.50 · Bull $23.00 · Bear $10.50
Data freshness
Prices
As of 2026-07-17
Fundamentals
As of 2026-07-16 • Vendor: Data Vendor v1
Scores
As of 2026-07-17 • Model: HYBRID_IC_RP
AI Memo
As of 2026-07-17 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-07-17
Investment thesis
As of 2026-07-17
Supporting evidence
What
Grade A · Constructive
Confidence Medium · Net Neutral
Target $20.00
Why
Momentum76 · Δ7d -10.2
Value42 · Δ7d 0.0
Sentiment73 · Δ7d -16.4
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.
Lead driver: Sentiment · See AI snapshot
Momentum
76
26% active weight
Current posture
7d trendSoftening
Δ7d
-10.2
Δ21d
-2.7
Value
42
39% active weight
Current posture
7d trendFlat
Δ7d
0.0
Δ21d
+0.2
Sentiment
73
34% active weight
Current posture
7d trendSoftening
Δ7d
-16.4
Δ21d
-3.2
Why this grade
Composite grade A. Momentum 76.2 / Value 41.6 / Sentiment 72.6
Fundamentals (TTM)As of 2026-07-16
Fundamentals (TTM)
As of 2026-07-16
Market Cap
$584.44M
Beta
0.52
Shares Out
41.33M
P/E (TTM) · Derived
-16.0
P/S (TTM)
1.81
P/FCF (TTM) · Derived
-169.14
Rev YoY
+8.9%
EPS YoY
+80.2%
Gross Margin
+50.9%
Op Margin
-12.5%
Net Debt
-$51.95M
Current Ratio
2.35
As of 2026-07-17 • Updated nightlySource: Internal modelMethodology